FundedIQ
Biotechnology

VRG Therapeutics: Funding, Investors & Team (Oct 2026)

VRG Therapeutics is a biotech firm specializing in miniprotein-based drugs and cellular and gene therapy technologies.

vrgtherapeutics.com LinkedIn Budapest, Hungary 11-50 employees
Total raised
$5.5M
Rounds
1
Latest
Series A
Aug 2023

VRG Therapeutics has raised $5.5M across 1 funding round on record, the most recent a Series A of $5.5M announced in Aug 2023.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

VRG Therapeutics Company Profile and Key Stats

Total funding raised
$5.5M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$5.5M in Aug 2023
Employees
11-50
reported band
Headquarters
Budapest, Hungary

Latest funding round on record: Aug 2023.

VRG Therapeutics Funding Rounds

Date
Round
Amount
Series A
$5.5M

VRG Therapeutics Founders and Leadership Team

Name
Role
Contact
Anna Hajdara
Founder
—

No contact details are on record for this team yet.

VRG Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
42
$7.2M
8,558
$15M

VRG Therapeutics' latest round of $5.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like VRG Therapeutics in Biotechnology and Budapest

Companies Similar to VRG Therapeutics

Ubives is an innovative user management tool that transforms the way online identification and data…

Pre-Seed $10k
Series B $150M

BioLinker is a creation of manufactured science, protein blend packs, and protein.

Undisclosed round $1.7M

WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs…

Series B $26.0M

Tydra Labs is a biotechnology company that transforms crustacean shell waste into chitin and bio-products.

Seed $420k

M-Based develops new alternative material technologies using mushrooms. 🍄 We consider environmental…

Seed $700k

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Turning biomass residues into fit-for-purpose microbial fertilizers, biostimulants and biocontrols.

Series A —

R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…

Series A $3.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

VRG Therapeutics Funding FAQs

What does VRG Therapeutics do?

VRG Therapeutics is a biotech firm specializing in miniprotein-based drugs and cellular and gene therapy technologies.

How much funding has VRG Therapeutics raised?

VRG Therapeutics has raised $5.5M across 1 round on record. The most recent is a Series A of $5.5M announced in Aug 2023.

When did VRG Therapeutics last raise funding?

VRG Therapeutics' most recent funding round on record is a Series A of $5.5M, announced in Aug 2023.

Who founded VRG Therapeutics?

FundedIQ lists Anna Hajdara (Founder) at VRG Therapeutics.

Where is VRG Therapeutics headquartered?

VRG Therapeutics is based in Budapest, Hungary.

How many employees does VRG Therapeutics have?

VRG Therapeutics is in the 11-50 employee band.

How does VRG Therapeutics' funding compare to other Biotechnology startups?

VRG Therapeutics' latest round of $5.5M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's VRG Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for VRG Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.